The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

BofA Securities has recently reduced Hims & Hers Health Inc (HIMS) stock to Underperform rating, as announced on November 14, 2024, according to Finviz. Earlier, on August 22, 2024, Needham had ...

Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board. The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled ...

STACKER — Research shows that comprehensive sex education reduces teen birth rates and sexually transmitted infections, ...

Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Joe Mazzulla is barely into his third year as the coach of the Celtics, but he's already established himself as one of the ...

Popular golf influencer Paige Spiranac has returned with another one of her weekly "Beginner's Guide to Golf" tutorial videos. This week she addresses ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...